Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the United States

• Váldodahkkit: Jonathan I. Silverberg (Dahkki), Feifei Yang (Dahkki), Evo Alemao (Dahkki), Jing Zhao (Dahkki), Concetta Crivera (Dahkki), Hetal V. Patel (Dahkki), Iris Lin (Dahkki), Aaron R. Mangold (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2024-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background The potential association of long‐term oral corticosteroid (OCS) use with adverse events (AEs) in patients with bullous pemphigoid (BP) is not well characterized in a real‐world setting. Objectives To evaluate the effect of OCS use and treatment duration on the incident AEs in pa...